Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function

Overview

Journal Clin Pharmacol Ther

Publisher Wiley

Specialty Pharmacology

Date 2016 Jul 23

PMID 27448090

Citations 17

Authors

S Y Chang

E J Weber

Kp Van Ness

D L Eaton

E J Kelly

Affiliations

Soon will be listed here.

Abstract

Because of complex cellular microenvironments of both the liver and kidneys, accurate modeling of transport function has remained a challenge, leaving a dire need for models that can faithfully recapitulate both the architecture and cell-cell interactions observed in vivo. The study of hepatic and renal transport function is a fundamental component of understanding the metabolic fate of drugs and xenobiotics; however, there are few in vitro systems conducive for these types of studies. For both the hepatic and renal systems, we provide an overview of the location and function of the most significant phase I/II/III (transporter) of enzymes, and then review current in vitro systems for the suitability of a transporter function study and provide details on microphysiological systems that lead the field in these investigations. Microphysiological modeling of the liver and kidneys using "organ-on-a-chip" technologies is rapidly advancing in transport function assessment and has emerged as a promising method to evaluate drug and xenobiotic metabolism. Future directions for the field are also discussed along with technical challenges encountered in complex multiple-organs-on-chips development.

Citing Articles

Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions.

Li J, Wang S, Tian F, Zhang S, Jin H Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145347 PMC: 9502688. DOI: 10.3390/ph15091126.

MatriGrid Based Biological Morphologies: Tools for 3D Cell Culturing.

Mai P, Hampl J, Baca M, Brauer D, Singh S, Weise F Bioengineering (Basel). 2022; 9(5).

PMID: 35621498 PMC: 9138054. DOI: 10.3390/bioengineering9050220.

New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.

Giacomini K, Yee S, Koleske M, Zou L, Matsson P, Chen E Clin Pharmacol Ther. 2022; 112(3):540-561.

PMID: 35488474 PMC: 9398938. DOI: 10.1002/cpt.2627.

Endoplasmic Reticulum Adaptation and Autophagic Competence Shape Response to Fluid Shear Stress in T24 Bladder Cancer Cells.

Del Favero G, Zeugswetter M, Kiss E, Marko D Front Pharmacol. 2021; 12:647350.

PMID: 34012396 PMC: 8126838. DOI: 10.3389/fphar.2021.647350.

Investigations on T cell transmigration in a human skin-on-chip (SoC) model.

Ren X, Getschman A, Hwang S, Volkman B, Klonisch T, Levin D Lab Chip. 2021; 21(8):1527-1539.

PMID: 33616124 PMC: 8058301. DOI: 10.1039/d0lc01194k.

References

Faber K, Muller M, Jansen P . Drug transport proteins in the liver. Adv Drug Deliv Rev. 2003; 55(1):107-24. DOI: 10.1016/s0169-409x(02)00173-4. View

Kelly E, Wang Z, Voellinger J, Yeung C, Shen D, Thummel K . Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res Ther. 2014; 4 Suppl 1:S17. PMC: 4029535. DOI: 10.1186/scrt378. View

Tabibian J, Masyuk A, Masyuk T, OHara S, LaRusso N . Physiology of cholangiocytes. Compr Physiol. 2013; 3(1):541-65. PMC: 3831353. DOI: 10.1002/cphy.c120019. View

Esch E, Bahinski A, Huh D . Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 2015; 14(4):248-60. PMC: 4826389. DOI: 10.1038/nrd4539. View

Ryan M, Johnson G, Kirk J, Fuerstenberg S, Zager R, Torok-Storb B . HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994; 45(1):48-57. DOI: 10.1038/ki.1994.6. View

Richert L, Liguori M, Abadie C, Heyd B, Mantion G, Halkic N . Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab Dispos. 2006; 34(5):870-9. DOI: 10.1124/dmd.105.007708. View

MacKay S, Funke A, Buffington D, Humes H . Tissue engineering of a bioartificial renal tubule. ASAIO J. 1998; 44(3):179-83. DOI: 10.1097/00002480-199805000-00011. View

Vivares A, Salle-Lefort S, Arabeyre-Fabre C, Ngo R, Penarier G, Bremond M . Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device. Xenobiotica. 2014; 45(1):29-44. DOI: 10.3109/00498254.2014.944612. View

Kuteykin-Teplyakov K, Luna-Tortos C, Ambroziak K, Loscher W . Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Br J Pharmacol. 2010; 160(6):1453-63. PMC: 2938816. DOI: 10.1111/j.1476-5381.2010.00801.x. View

10.

Yamazaki M, Neway W, Ohe T, Chen I, Rowe J, Hochman J . In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J Pharmacol Exp Ther. 2001; 296(3):723-35. View

11.

Sahi J . Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates. Expert Opin Drug Metab Toxicol. 2006; 1(3):409-27. DOI: 10.1517/17425255.1.3.409. View

12.

Niemi M, Pasanen M, Neuvonen P . Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011; 63(1):157-81. DOI: 10.1124/pr.110.002857. View

13.

Jang K, Poyan Mehr A, Hamilton G, McPartlin L, Chung S, Suh K . Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb). 2013; 5(9):1119-29. DOI: 10.1039/c3ib40049b. View

14.

Sung J, Kam C, Shuler M . A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip. 2010; 10(4):446-55. DOI: 10.1039/b917763a. View

15.

Sarkar U, Rivera-Burgos D, Large E, Hughes D, Ravindra K, Dyer R . Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab Dispos. 2015; 43(7):1091-9. PMC: 4468434. DOI: 10.1124/dmd.115.063495. View

16.

Humes H, Weitzel W, Bartlett R, Swaniker F, Paganini E, Luderer J . Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004; 66(4):1578-88. DOI: 10.1111/j.1523-1755.2004.00923.x. View

17.

Kanai N, Lu R, Satriano J, Bao Y, Wolkoff A, Schuster V . Identification and characterization of a prostaglandin transporter. Science. 1995; 268(5212):866-9. DOI: 10.1126/science.7754369. View

18.

Schaefer O, Ohtsuki S, Kawakami H, Inoue T, Liehner S, Saito A . Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes. Drug Metab Dispos. 2011; 40(1):93-103. DOI: 10.1124/dmd.111.042275. View

19.

Ballatori N, Li N, Fang F, Boyer J, Christian W, Hammond C . OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids. Front Biosci (Landmark Ed). 2009; 14(8):2829-44. PMC: 2694352. DOI: 10.2741/3416. View

20.

Andersen M, Betts K, Dragan Y, Fitzpatrick S, Goodman J, Hartung T . Developing microphysiological systems for use as regulatory tools--challenges and opportunities. ALTEX. 2014; 31(3):364-7. PMC: 4778746. DOI: 10.14573/altex.1405151. View